Business Wire - July 11, 2002
"It is imperative that we continue to look for creative, efficient and clinically sound ways to improve the quality of care and support provided to all people living with and affected by HIV/AIDS, regardless of economic status, or location in the world," said IAPAC president and chief executive officer Jose M. Zuniga. "IAPAC is collaborating with TherapyEdge because TherapyEdge HIV is a sound example of how technology can measurably improve peoples' lives. It also presents the immediate opportunity to advance and accelerate the quality of care for men, women and children living with HIV by instantly providing care providers with access to the latest in clinical breakthroughs and information regardless of its origin."
TherapyEdge HIV graphically tracks and automatically processes a patient's clinical data - including medical conditions, medications, genetic tests for drug resistance, drug efficacy and toxicity data - through an extensive knowledge base of pharmacological and clinical information created and maintained in collaboration with world-renowned HIV clinicians and researchers. The system utilizes its advanced AI engine and knowledge base to instantly assess a patient's current status and generate patient-specific, optimized treatment alternatives that clinicians can review and compare. Clinicians can use the system to rapidly transform disparate data into individualized comprehensive treatment plans for patients. TherapyEdge distributes this actionable medical knowledge anywhere in the world to subscribers via a standard web-browser.
TherapyEdge's real-time, intelligent alerting system automatically checks for drug interactions, medical conditions or side-effect issues, as well as abnormal lab results and drug dosing. Additionally, the system de-identifies patient data and provides a longitudinal database that can be queried for drug efficacy data, clinical outcomes and quality of care information. The system therefore supports the validation of effectiveness of health services and therapeutic interventions.
"TherapyEdge is excited about IAPAC's endorsement of our technology and is honored to actively collaborate with the association on a global basis," said Joseph R. Sollee, TherapyEdge's chief executive officer. "TherapyEdge HIV enables clinicians to effectively manage the massive amount of available information on HIV treatment and deliver the most effective, individualized therapies in a cost-effective, time-efficient manner."
About IAPAC
The International Association of Physicians in AIDS Care (IAPAC) is a nonprofit professional association, headquartered in Chicago, that represents over 12,000 physicians and other healthcare professionals in 89 countries. Founded in 1995, IAPAC develops and implements global educational and advocacy strategies to better the quality of care for all people living with HIV/AIDS and associated co-infectious diseases.
The association publishes IAPAC Monthly, JIAPAC--a quarterly peer-reviewed clinical journal, a variety of clinical management tools for HIV-treating physicians, and a host of other healthcare professional and patient reference and education materials. Additionally, through the strength of its global membership and regional offices in Johannesburg and Paris, IAPAC is able to deliver educational and training programs such as the Global AIDS Learning & Evaluation Network (GALEN) to build HIV care capacity the world over. For more information about IAPAC, visit the association's new Web site at www.iapac.org.
About TherapyEdge
TherapyEdge, Inc., based in Durham, N.C., is a medical information services company that uses patented technology to create products for both clinicians and healthcare companies. TherapyEdge combines advanced artificial intelligence (AI) with clinical evidence and expert human knowledge to produce cutting-edge, decision support software for individualized patient care. TherapyEdge's proprietary technology efficiently captures and analyzes comprehensive, patient-level, clinical outcomes data, providing greater insight regarding quality of care, best practices, and the effectiveness of drugs and diagnostic testing. The Company exercises stringent privacy procedures and security precautions to protect the confidentiality of patient and physician data and to comply with heightened laws and regulations concerning information privacy (including HIPAA). For more information about TherapyEdge, visit www.TherapyEdge.com.
CONTACT: Indicium Communications Edward S. Levens, 919/821-1059 ext. 104 eslevens@indicium.com
SOURCE: TherapyEdge, Inc.
020711
BW020716
Copyright © 2002 - Business Wire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Business Wire, Permissions Desk, Business Wire, 1185 Avenue of the Americas, 3rd Floor, New York, NY 10036; Tel: (212) 575-8822; FAX: (212) 575-1854. http://www.businesswire.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2002. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2002. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .